The U.S. Could See Another Spike in COVID Cases


[ad]

The pandemic is getting worse – again.

While COVID tensions cooled in the U.S. that may not be the case for much longer.

In fact, experts are warning the U.S. could see another spike in cases, with some wastewater samples showing an increase in infections.

According to the U.S. CDC, as noted by People, “The U.S. is also starting to see an increase of COVID-19 in wastewater samples, a strong early predictor of when the virus is about to spike. Between Feb. 24 and March 10, the presence of COVID-19 increased by 100% or more in 37% of U.S. wastewater sites, according to the Centers for Disease Control’s tracking system.”

Oh Joy!


[ad]

China is seeing outbreaks. Millions are on lockdown again. Schools are closed.

“China, the last major country to relentlessly pursue a Covid-zero policy, reported 1,437 cases across dozens of cities on Monday. That’s a fourfold jump in a week,” says ABC News.

Even the German Health Minister says the situation has become “critical.”

“We are in a situation that I would like to describe as critical,” Lauterbach said at the weekly coronavirus press briefing in Berlin. “We have strongly rising case figures again. […] I keep reading that the omicron variant is a milder variant but that’s only true to a limited extent.”

On top of that, there’s another variant making the rounds. Called Deltacron, reports say this one combines the elements of delta and omicron. It’s already been spotted in France, the Netherlands, and in Denmark.

In short, here we go again.

Should we see a bigger resurgence of cases, pay attention to vaccine stocks like Pfizer (PFE), for example. where CEO Albert Bourla says a fourth booster vaccine is necessary.

As reported by NBC News, “Bourla said Friday that Pfizer’s scientists are now seeing the protection from the initial booster shot begin to wane against omicron after three or four months, meaning a fourth dose may be needed.”

There’s also Moderna (MRNA)—which jumped from $120 to $160 in recent days. Even BioNTech (BNTX) jumped from $120 to $160.

Previous

Next